Halozyme Therapeutics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (49)

Latest Posts

About This Stock More About This Stock
Stock Charts To Watch - Tuesday, Jan. 14
Article By: Harry Boxer
Tuesday, January 14, 2020 10:27 PM EDT
Aimmune Therapeutics, Inc. has had a beautiful uptrend since it spiked in Sept, pulled back in a falling wedge, popped out of the wedge and ran up to the resistance level, formed another falling wedge, and then ran five waves up.
In this article: RAD, HALO, IRIX, AGTC, AIMT, DNLI
Read
Four Homerun Biotech Stocks Too Cheap By A Half
Article By: Bret Jensen
Sunday, February 21, 2016 12:38 PM EDT
Valuations this cheap haven’t been available in biotech since 2011, and buying any of these four stocks right now could be one of your best investing decisions of 2016.
In this article: HALO, AGEN, BDSI, EGRX, INCY, GILD, ABBV Also: MRK, ENDP, TEVA
Read
My Bet’s Still On Biotech — 11 Stocks On Sale Today
Article By: Bret Jensen
Friday, August 28, 2015 3:42 PM EDT
Market uncertainty has been slowly building this year culminating in Monday’s ‘flash crash’. But, there is one certainty in the market; if you’re looking for growth there is no better sector than biotech, and these are the top stocks in the sector.
In this article: SGYP, AVEO, HALO, PGNX, AMGN, BIIB, CELG, GILD, AGEN, ABBV, EGRX
Read
Don’t Get Caught When This Bubble Bursts
Article By: Bret Jensen
Tuesday, July 21, 2015 10:18 PM EDT
The enthusiasm for the small cap biotech sector is quite something right now. This is understandable given the top gainers within the market during the first half of 2015 is dominated by names from this space but this sort of rally cannot continue.
In this article: CELG, EGRX, GILD, HALO, JUNO, RCPT, SGYP, ZIOP
Read
5 Healthy Stocks In The Top Biotech ETF
Article By: Zacks Investment Research
Wednesday, June 17, 2015 1:42 PM EDT
The pharma stocks are soaring, but the biotech is the real winner, having emerged as a leader yet gain in the health care world and the broader market from the year-to-date look.
In this article: ANAC, GEVA, HALO, HZNP, IMGN Also: SBIO
Read

Latest Tweets for $HALO

No tweets yet!

PARTNER HEADLINES